Side-by-side comparison of AI visibility scores, market position, and capabilities
Agentic cybersecurity platform. Record $130M Series A (largest cyber A round ever). $166M total. 2.5M+ alerts processed. Founded 2024, Boston. Private.
7AI is an agentic cybersecurity company founded in 2024 and headquartered in Boston, Massachusetts, built on the mission of deploying AI agents to autonomously triage, investigate, and respond to security alerts at a scale impossible for human analysts. The company's core technology uses purpose-built AI agents that operate within security operations centers, ingesting alert streams and acting on them continuously — a direct answer to the chronic understaffing and alert fatigue that define modern SOC operations.\n\nThe 7AI platform focuses on agentic security operations, where AI agents handle the repetitive, high-volume investigation tasks that consume analyst time. By automating alert triage and incident investigation, the platform allows human security professionals to concentrate on complex threat hunting and strategic response rather than routine ticket work. The company has processed more than 2.5 million alerts since its founding, demonstrating operational scale at an early stage.\n\n7AI raised a record $130 million Series A — the largest cybersecurity Series A ever recorded — bringing total funding to $166 million. This extraordinary early-stage investment reflects conviction among top-tier investors that the agentic AI layer in cybersecurity will be one of the most valuable platform opportunities of the decade. With the SOC automation market accelerating as the global cybersecurity talent shortage deepens, 7AI's combination of agentic architecture and landmark funding positions it as a defining company in the next generation of enterprise security operations.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.